Clinical Trial Update: Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating fluorodopa F-18 as an imaging tracer for congenital hyperinsulinism and insulinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism
• Insulinoma

Drugs mentioned

• Fluorodopa F-18 (18F-fluorodopa)

Snippet

Sponsor: Cook Children's Health Care System | Conditions: Congenital Hyperinsulinism, Insulinoma | Phase 1 | Status: RECRUITING